Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.
Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered.
This volume will be of particular interest to students and professionals engaged in the fields of medicine, biomedical and biopharmaceutical sciences.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.
Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered.
This volume will be of particular interest to students and professionals engaged in the fields of medicine, biomedical and biopharmaceutical sciences.
Imprint | Springer |
Country of origin | Netherlands |
Release date | December 2010 |
Availability | Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available. |
First published | 2004 |
Editors | Hubert Hondermarck |
Dimensions | 235 x 155mm (L x W) |
Format | Paperback |
Pages | 396 |
Edition | Softcover reprint of the original 1st ed. 2004 |
ISBN-13 | 978-90-481-6637-4 |
Barcode | 9789048166374 |
Categories | |
LSN | 90-481-6637-3 |